What does ImmunoPrecise Antibodies Ltd. do?

Jun 22 2025 06:55 PM IST
share
Share Via
ImmunoPrecise Antibodies Ltd. is a Canadian micro-cap company specializing in custom hybridoma development services for the Pharmaceuticals & Biotechnology industry. As of January 2025, it reported net sales of $4 million and a net loss of $15 million, with a market cap of $43.31 million.
Overview:
ImmunoPrecise Antibodies Ltd. is a Canada-based supplier of custom hybridoma development services in the Pharmaceuticals & Biotechnology industry, categorized as a micro-cap company.

Financial Snapshot:
Most recent Net Sales: 4 Million (Quarterly Results - Jan 2025)
Most recent Net Profit: -15 Million (Quarterly Results - Jan 2025)
Market cap: USD 43.31 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -0.45
Return on Equity: -41.78%
Price to Book: 2.50

Contact Details:
Address: 880 - 580 HORNBY STREET, VANCOUVER BC : V6C3B6
Tel: ['1 604 8060626', '1 438 8637071']
Fax: 1 250 4830309
Website: https://immunoprecise.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
How big is ImmunoPrecise Antibodies Ltd.?
Jun 22 2025 06:10 PM IST
share
Share Via